Tema Oncology ETF (CANC) Dividend Yield, Date & History $24.45 +0.14 (+0.58%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Dividend Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Tema Oncology ETF Dividend SummaryDividend Yield2.94%Annual Dividend$0.72Recent Dividend Payment Dec. 12 Tema Oncology ETF (CANC) pays an annual dividend of $0.72 per share, with a dividend yield of 2.94%. The next annual payment of $0.7283 per share was paid on Thursday, December 12, to investors who owned the stock before the ex-dividend date of Wednesday, December 11. Get Dividend Stock Ideas Daily Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news. Enter your email to sign up for newsletter Sign Up Skip Charts & View Dividend HistoryCANC Dividend Payments by QuarterDividend Payments by Quarter Chart DescriptionThe chart below displays up to four years of Tema Oncology ETF's dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.Open Tema Oncology ETF in Dividend Calculator CANC Dividend Yield Over TimeDividend Yield Over Time Chart DescriptionThe chart below tracks Tema Oncology ETF's dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.Open Tema Oncology ETF in Dividend Yield Calculator Ad DTICackling Kamala hates this companyDo you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. Tema Oncology ETF vs. The CompetitionCompare Tema Oncology ETF's annual dividend, yield, and 3-year growth rate with averages for and NASDAQ companies to evaluate its performance against the market.TypeTema Oncology ETF CompaniesNASDAQ CompaniesAnnual Dividend$0.72$0.01$1.31Dividend Yield2.94%14.65%4.23%Annualized 3-Year Dividend Growth0.00%33.61%14.22% Tema Oncology ETF Dividend History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years All Time Time Frame * Start Date * End Date AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date12/10/2024$0.7283+$0.5792388.41%12/11/202412/11/202412/12/202412/12/2023Variable$0.1491 - 12/13/202312/14/202312/15/2023This table shows Tema Oncology ETF's annualdividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time. Tema Oncology ETF Dividend - Frequently Asked Questions What is Tema Oncology ETF's dividend yield? The current dividend yield for Tema Oncology ETF is 2.94%. Learn more on CANC's dividend yield history. How much is Tema Oncology ETF's annual dividend? The annual dividend for CANC shares is $0.72. Learn more on CANC's annual dividend history. How often does Tema Oncology ETF pay dividends? Tema Oncology ETF pays annual dividends to shareholders. When was Tema Oncology ETF's most recent dividend payment? Tema Oncology ETF's most recent annual dividend payment of $0.7283 per share was made to shareholders on Thursday, December 12, 2024. When was Tema Oncology ETF's most recent ex-dividend date? Tema Oncology ETF's most recent ex-dividend date was Wednesday, December 11, 2024. When did Tema Oncology ETF last increase or decrease its dividend? The most recent change in the company's dividend was an increase of $0.5792 on Tuesday, December 10, 2024. More Dividend Resources from MarketBeat Related Companies SARK Dividend UFO Dividend FDFF Dividend FDNI Dividend DEMZ Dividend PABD Dividend BITS Dividend GFGF Dividend FMED Dividend CTEC Dividend Dividend Tools Dividend Announcements Dividend Calculator Dividend Capture Stocks Dividend Cuts Dividend Increases Dividend Investing Guide Dividend Newsletter Dividend Payout Ratio Calculator Dividend Screener Dividend Stocks Overview Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Special Dividends Stock Lists Dividend Announcements Dividend Calculator Dividend Capture Stocks Dividend Cuts Dividend Increases Dividend Investing Guide Dividend Newsletter Dividend Payout Ratio Calculator Dividend Screener Dividend Stocks Overview Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Special Dividends Latest Articles ABM Industries Stock: A Dividend King at a DiscountMedtronic: A Dividend Aristocrat Powering Up for 2025 and Beyond3 Best Dividend Stocks to Buy as Interest Rates FallIntuit Beats Q4 Earnings: AI, Dividends, and a Growth Strategy3 High-Yield Dividend Stocks for Income Now and Growth LaterDividend King ABM Industries is on Track for New HighsWhy Altria Stock is Still a Good Dividend PlayGet Paid While You Wait - OneMain's Juicy DividendsAlphabet Changes the Narrative with Its First-Ever Dividend More Dividend News Cackling Kamala hates this company (Ad)Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. This page (NASDAQ:CANC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
